Ernexa Therapeutics, Inc. (ERNA)
1.88
+0.05
(+2.73%)
USD |
NASDAQ |
Nov 06, 16:00
1.85
-0.03
(-1.60%)
After-Hours: 20:00
Ernexa Therapeutics Total Long Term Debt (Quarterly) : 0.138M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.138M |
| June 30, 2026 | 0.182M |
| March 31, 2026 | 0.226M |
| December 31, 2025 | 0.277M |
| September 30, 2025 | 0.346M |
| June 30, 2025 | 0.376M |
| March 31, 2025 | 0.419M |
| December 31, 2024 | 0.477M |
| September 30, 2024 | 32.57M |
| June 30, 2024 | 44.94M |
| March 31, 2024 | 44.58M |
| December 31, 2023 | 39.63M |
| September 30, 2023 | 38.45M |
| June 30, 2023 | 34.96M |
| March 31, 2023 | 0.841M |
| December 31, 2022 | 0.887M |
| September 30, 2022 | 2.326M |
| June 30, 2022 | 2.433M |
| March 31, 2022 | 1.018M |
| December 31, 2021 | 2.297M |
| September 30, 2021 | 2.411M |
| June 30, 2021 | 2.839M |
| March 31, 2021 | 2.137M |
| December 31, 2020 | 2.215M |
| September 30, 2020 | 3.376M |
| Date | Value |
|---|---|
| June 30, 2020 | 3.297M |
| March 31, 2020 | 4.808M |
| December 31, 2019 | 5.671M |
| September 30, 2019 | 6.026M |
| June 30, 2019 | 6.464M |
| March 31, 2019 | 6.736M |
| December 31, 2018 | 3.815M |
| September 30, 2018 | 4.285M |
| June 30, 2018 | 4.968M |
| March 31, 2018 | 5.185M |
| December 31, 2017 | 5.407M |
| September 30, 2017 | 5.552M |
| June 30, 2017 | 5.797M |
| March 31, 2017 | 8.127M |
| December 31, 2016 | 8.525M |
| September 30, 2016 | 8.416M |
| June 30, 2016 | 8.436M |
| March 31, 2016 | 8.734M |
| December 31, 2015 | 7.654M |
| September 30, 2015 | 6.756M |
| June 30, 2015 | 5.823M |
| March 31, 2015 | 4.905M |
| December 31, 2014 | 5.377M |
| September 30, 2014 | 4.527M |
| June 30, 2014 | 3.79M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Cerenome, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 57.32M |
| Alnylam Pharmaceuticals, Inc. | 2.951B |
| Anika Therapeutics, Inc. | 24.56M |
| Savara, Inc. | 30.11M |